论文著作：
1. Li Z†, Guo Z†, Lu X†, Ma X, Wang X, Zhang R, Hu X, Wang Y, Pang J, Fan T, Liu Y, Tang S, Fu H, Zhang J,Li Y*, You X*, Song D*. Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs. Acta Pharm Sin B, 2023,2023, 13(7):3067-3079. IF 14.5
2. Li Y†, Zhang Y†; Niu T, Pang Y, Shi Y, Zeng Q, Zhang J, Zhu J, Zhong X, Wang Y, Wang Y, Tang S, Kong W*, Song D*, Jiang J*. Discovery and development of tricyclic matrinic derivatives as anti-diabetic candidates by AMPKα activation. Chin. Chem. Lett. 2023, 34,107561.IF 9.1
3. Bao Y†, Niu T†, Zhu J†, Mei Y, Shi Y, Meng R, Duan Q, Zhang N, Fan T, Wang Y, Pang Y, Li Y*, He H*, Song D*. Evolution and Discovery of Matrine Derivatives as a New Class of Anti-Hepatic Fibrosis Agents Targeting Ewing Sarcoma Breakpoint Region 1 (EWSR1).J Med Chem.2023, 66(12):7969-7987. IF 7.3 (back cover article)
4. Zeng QX†, Wei W†, Fan TY, Deng HB, Guo XX, Zhao LP, Zhang XT, Tang S, Jiang JD, Li YH*,Wang YX*, Song DQ*. Capture and Identification of Dual Specificity Mitogen-Activated Protein Kinase Kinase 7 as a Direct Proteomic Target of Berberine to Affect the c-JunN-Terminal Kinase Pathway. CCS Chem. 2022, 4, 1954–1963. IF 11.2
5. Zeng Q†, Deng H†, Li Y†, Fan T, Liu Y, Tang S, Wei W, Liu X, Guo X, Jiang J, Wang Y*, Song D*. Berberine Directly Targets the NEK7 Protein to Block the NEK7-NLRP3 Interaction and Exert Anti-inflammatory Activity. J Med Chem. 2021, 64(1):768-781. IF 8.0(cover article)
李迎红
北京市
研究领域：
生物医药
研究方向：
抗感染抗肿瘤药物的药物化学与化学生物学
所在单位：
中国医学科学院北京协和医学院
